Frequently Asked Questions What is the primary difference in how MOTS-c and Tesofensine work
MOTS-c is a mitochondrial-derived peptide studied for how it influences glucose use, insulin sensitivity, and fuel flexibility
GHK-Cus lack of side effects has been cited by multiple researchers [3, 8, 9], and it has consistently been found to be non-toxic and a non-irritant [16]
It is particularly beneficial for those with sensitive or dull skin
Published Phase 2 data shows: Dose Group Discontinuation Due to AE Placebo 0% 1 mg 2.9% 4 mg (escalated) 5.7% 8 mg (escalated) 5.0% 12 mg (escalated) 8.3% For context, discontinuation rates in semaglutide 2.4 mg trials (STEP program) were approximately 7%, and tirzepatide 15 mg trials (SURMOUNT) reported approximately 6-7%
It starts getting delivered to the skin cells first and then from there, it transports the rest of the body through the cells